This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.81% per year. These returns cover a period from January 1, 1988 through November 3, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Earnings ESP: Archive
3 Insurance Stocks Poised to Outshine Q2 Earnings Expectations
by Sushmita Sarker
Prudent pricing, exposure growth, solid retention, renewals, and improved digitalization are expected to help AIG, MFC, and PRI outperform second-quarter estimates.
AIGPositive Net Change MFCNegative Net Change PRIPositive Net Change
insurance
4 Auto Stocks Likely to Outperform Q2 Earnings Estimates
by Lavina Shahu
CMI, RIVN, LCID, and AXL are poised to beat Q2 estimates despite industry headwinds and weaker sector earnings.
CMINegative Net Change AXLNegative Net Change LCIDNegative Net Change RIVNPositive Net Change
auto-tires-trucks electric-vehicles
4 Utility Stocks Poised to Outperform in the Upcoming Earnings Cycle
by Tanvi Sarawagi
Here are four utility stocks that are expected to post an earnings beat this reporting cycle.
SRENegative Net Change MDUNegative Net Change SRPositive Net Change OGSNegative Net Change
utilities
3 Transportation Stocks Positioned to Surpass Q2 Earnings Estimates
by Maharathi Basu
Transportation stocks like EXPD, GXO and ZIM have the potential to deliver better-than-expected Q2 earnings.
EXPDNegative Net Change ZIMNegative Net Change GXONegative Net Change
transportation
4 Technology Stocks Poised to Beat Earnings Estimates in Q2
by Aniruddha Ganguly
Here, we have picked four technology stocks, META, LRCX, FLEX and STX, which are likely to pull off earnings surprises in second-quarter 2025.
STXNegative Net Change LRCXNegative Net Change FLEXNegative Net Change METANegative Net Change
artificial-intelligence semiconductor tech-stocks
5 Drug/Biotech Stocks Likely to Outperform Q1 Earnings Estimates
by Ahan Chakraborty
Let us look at some drug/biotech stocks, NVO, PCRX, RARE, ACAD and DNLI, which are poised to beat on first-quarter 2025 earnings.
NVONegative Net Change PCRXPositive Net Change RAREPositive Net Change ACADPositive Net Change DNLIPositive Net Change
biotechnology biotechs medical pharmaceuticals
4 Energy Firms Likely to Outperform Q1 Earnings Estimates
by Turjya Saha
Energy sector stocks such as ET, MPLX, PBA, and COP show signs of robust performance ahead of Q1 earnings.
COPNegative Net Change ETPositive Net Change MPLXPositive Net Change PBAPositive Net Change
energy oil-energy
4 MedTech Stocks Poised to Outshine Q1 Earnings Estimates
by Indrajit Bandyopadhyay
MedTech companies' quarterly results are likely to reflect base business recovery on a year-over-year basis. Let's see how HIMS, GMED, QDRL and HAE are poised ahead of their earnings release.
HAENegative Net Change QDELNegative Net Change GMEDNegative Net Change HIMSNegative Net Change
medical medical-devices
3 Gold Mining Stocks Poised to Outshine Q1 Earnings Estimates
by Anindya Barman
Gold mining companies' results are expected to reflect the benefits of higher prices and efforts to reduce costs. KGC, SAND and IAG look set to beat earnings estimates this season.
KGCNegative Net Change IAGNegative Net Change
basic-materials gold
4 Software Stocks Likely to Beat Earnings Estimates This Season
by Anirudha Bhagat
Let us examine some software stocks, such as AFRM, XYZ, BILL and TEAM, which are poised to beat earnings estimates this season.
TEAMNegative Net Change BILLNegative Net Change AFRMNegative Net Change XYZPositive Net Change
artificial-intelligence cloud-computing computers earnings saas tech-stocks
5 Construction Stocks Set to Carve a Beat in Q1 Earnings
by Shrabana Mukherjee
Federal spending drives growth, but high rates and labor shortages weigh on construction in 2025. DFH, PRIM, PCH, MLM and MTZ from the Zacks Construction sector are set to beat expectations.
MLMNegative Net Change PCHNegative Net Change PRIMNegative Net Change MTZNegative Net Change DFHPositive Net Change
construction earnings
4 REITs Poised to Shine Bright in the Upcoming Earnings Reports
by Moumita C. Chattopadhyay
REITs support diverse real and virtual activities, and WELL, EQIX, EQR, and WPC are likely to reflect that strength in their upcoming earnings.
EQRPositive Net Change EQIXNegative Net Change WPCNegative Net Change WELLPositive Net Change
earnings finance reit
3 Transportation Stocks Poised to Surpass Q1 Earnings Estimates
by Maharathi Basu
Transportation stocks like EXPD, JBLU and GXO have the potential to deliver better-than-expected Q1 earnings.
JBLUPositive Net Change EXPDNegative Net Change GXONegative Net Change
airlines transportation
3 Waste Removal Firms Poised to Beat Estimates This Earnings Season
by Shuvra Shankar Dey
Here, we pick three waste removal service stocks, namely, Casella Waste Systems (CWST), Waste Connections (WCN), WM (WM), which are likely to pull off earnings surprises this season.
WMPositive Net Change CWSTPositive Net Change WCNPositive Net Change
business-services earnings
4 Insurance Stocks Poised to Surpass Q1 Earnings Expectations
by Sushmita Sarker
Better pricing, exposure growth, accelerated digitalization and sturdy capital are expected to help BRO, PLMR, AIZ and PRI outperform first-quarter estimates.
AIZPositive Net Change BROPositive Net Change PRIPositive Net Change PLMRPositive Net Change
insurance
Buy Walmart Stock on Likely Q4 Earnings Beat and Ongoing Rally
by Nalak Das
Walmart Inc. (WMT) has been gaining from its sturdy comp sales, driven by its constant expansion efforts and splendid e-commerce performance.
AMZNNegative Net Change WMTPositive Net Change
retail
3 Service Firms Poised to Beat Estimates in Q4 Earnings
by Zacks Equity Research
Here, we pick three business service stocks, namely, Block (XYZ), Coinbase (COIN) and V2X (VVX), which are likely to pull off earnings surprises this season.
COINNegative Net Change VVXNegative Net Change XYZPositive Net Change
business-services earnings
High-Flying Twilio a Must-Buy Ahead of Q4 Earnings to Tap More Upside
by Nalak Das
Twilio has been benefiting from accelerated digital transformations amid a growing hybrid working trend.
GOOGLNegative Net Change TWLONegative Net Change
internet
3 Transportation Stocks Positioned to Surpass Q4 Earnings Estimates
by Maharathi Basu
Transportation stocks like ACDVF, VLRS and GLNG have the potential to deliver better-than-expected fourth-quarter results.
UALNegative Net Change VLRSPositive Net Change GLNGNegative Net Change ACDVFPositive Net Change
airlines transportation
3 Leisure Stocks Poised to Beat Earnings Estimates in Q4
by Mrithunjoy Kaushik
The leisure industry is poised to benefit from rising consumer spending, business modifications and AI-driven technological enhancements.
FUNNegative Net Change AMCNegative Net Change PLNTPositive Net Change
consumer-discretionary earnings
3 Energy Stocks Positioned to Surpass Earnings Estimates in Q4
by Urbashi Dutta
Energy stocks like PR, AM and TRP have the potential to deliver better-than-expected earnings results in Q4.
AMNegative Net Change TRPPositive Net Change ARNegative Net Change PRNegative Net Change
energy oil-energy
Buy Amazon Ahead of Earnings Today on Strong EPS Estimate Revisions
by Nalak Das
AMZN reported record business in the 2024-25 holiday season in terms of both sales and items sold.
AMZNNegative Net Change MSFTNegative Net Change GOOGLNegative Net Change
internet internet-content tech-stocks
3 REITs Likely to Turn Out Winners This Earnings Season
by Moumita C. Chattopadhyay
With the REIT industry offering a real estate structure for several economic activities, real or virtual, there are pockets of strength. This is likely to be reflected in the earnings releases of KIM, AMH and VNO.
VNOPositive Net Change KIMPositive Net Change AMHNegative Net Change CBRENegative Net Change
finance reit
4 Insurers Poised to Outperform Estimates This Earnings Season
by Tanuka De
Better pricing, exposure growth, accelerated digitalization and sturdy capital are expected to help PLMR, AIZ, BHF and UNM outperform fourth-quarter estimates.
AIZPositive Net Change UNMPositive Net Change BHFNo Net Change PLMRPositive Net Change
earnings finance insurance
Are These 5 Biotech Stocks Set to Beat Q4 Earnings Estimates?
by Sundeep Ganoria
Let us look at some biotech stocks, AMGN, CRSP, MRNA, SRPT and VRTX, which are poised to beat on fourth-quarter earnings.
AMGNPositive Net Change VRTXPositive Net Change MRNANegative Net Change SRPTNegative Net Change CRSPNegative Net Change
biotechs earnings medical pharmaceuticals